Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Neelu Kalra & Timothy Craig. (2014) Icatibant for the treatment of hereditary angioedema. Expert Opinion on Orphan Drugs 2:7, pages 743-750.
Read now
Read now
Jonathan A. Bernstein & Joseph J. Moellman. (2012) Progress in the Emergency Management of Hereditary Angioedema: Focus on New Treatment Options in the United States. Postgraduate Medicine 124:3, pages 91-100.
Read now
Read now
Laurence Bouillet. (2011) Icatibant in hereditary angioedema: news and challenges. Expert Review of Clinical Immunology 7:3, pages 267-272.
Read now
Read now
Lilian Varga & Henriette Farkas. (2011) rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Expert Review of Clinical Immunology 7:2, pages 143-153.
Read now
Read now
Articles from other publishers (20)
Adam D Jakes, Iona Thorne, John Guly, Sorena Kiani-Alikhan & Anita Banerjee. (2020) Case report: Hereditary angioedema in pregnancy. Obstetric Medicine 14:3, pages 177-180.
Crossref
Crossref
Conor Dass, Maggie Mahaffa, Elizabeth Dang, Ronna Campbell, Zuhair Ballas & Sangil Lee. (2021) Evaluation of staging criteria for disposition and airway intervention in emergency department angioedema patients. Acute Medicine & Surgery 8:1.
Crossref
Crossref
Viviana Piras, Francisca Alves & Margarida Gonçalo. (2019) Self‐administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema. Dermatologic Therapy 32:6.
Crossref
Crossref
Philippa Adams & Stephanie Kilinç. (2019) The lived experience of women who have Hereditary Angioedema: An exploratory study. Health Psychology Update 28:1, pages 23-31.
Crossref
Crossref
Takahiko Horiuchi, Michihiro Hide, Kouhei Yamashita & Isao Ohsawa. (2018) The use of tranexamic acid for on-demand and prophylactic treatment of hereditary angioedema-A systematic review. Journal of Cutaneous Immunology and Allergy 1:4, pages 126-138.
Crossref
Crossref
Honglu Chao, Yinlong Liu, Chao Lin, Xiupeng Xu, Zheng Li, Zhongyuan Bao, Liang Fan, Chao Tao, Lin Zhao, Yan Liu, Xiaoming Wang, Yongping You, Ning Liu & Jing Ji. (2018) Activation of bradykinin B2 receptor induced the inflammatory responses of cytosolic phospholipase A2 after the early traumatic brain injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:9, pages 2957-2971.
Crossref
Crossref
Jonathan A. Bernstein, Paolo Cremonesi, Thomas K. Hoffmann & John Hollingsworth. (2017) Angioedema in the emergency department: a practical guide to differential diagnosis and management. International Journal of Emergency Medicine 10:1.
Crossref
Crossref
Constance H. Katelaris. (2017) Acute Management of Hereditary Angioedema Attacks. Immunology and Allergy Clinics of North America 37:3, pages 541-556.
Crossref
Crossref
J. Rohart, L. Bouillet & H. Moizan. (2017) Prise en charge des patients atteints d’angiœdèmes bradykiniques en chirurgie orale et maxillo-faciale. Journal of Stomatology, Oral and Maxillofacial Surgery 118:2, pages 109-114.
Crossref
Crossref
Regis Albuquerque Campos, Solange Oliveira Rodrigues Valle, Alfeu Tavares França, Elisabete Cordeiro, Faradiba Sarquis Serpa, Yara Ferreira Mello, Teresinha Malheiros, Eliana Toledo, Elie Mansour, Gustavo Fusaro & Anete Sevciovic Grumach. (2014) Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study. Sao Paulo Medical Journal 132:5, pages 261-265.
Crossref
Crossref
Neil H. Crooks, Jaimin Patel, Lavanya Diwakar & Fang Gao Smith. (2014) Icatibant in the Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Case Reports in Critical Care 2014, pages 1-3.
Crossref
Crossref
Jan Over, Christine Kramer, Anky Koenderman, Diana Wouters & Sacha Zeerleder. 2013. Production of Plasma Proteins for Therapeutic Use. Production of Plasma Proteins for Therapeutic Use
241
258
.
M. Baş, J. Greve, T. K. Hoffmann, A. Reshef, W. Aberer, M. Maurer, S. Kivity, H. Farkas, B. Floccard, F. Arcoleo, L. Martin, B. Sitkauskiene, L. Bouillet, P. Schmid-Grendelmeier, H. Li & A. Zanichelli. (2013) Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study. Allergy 68:11, pages 1452-1459.
Crossref
Crossref
Sujai Jalaj & James S. Scolapio. (2013) Gastrointestinal Manifestations, Diagnosis, and Management of Hereditary Angioedema. Journal of Clinical Gastroenterology 47:10, pages 817-823.
Crossref
Crossref
A.S. Grumach, S.O.R. Valle, E. Toledo, D. de Moraes Vasconcelos, M.M.S. Villela, E. Mansour, J.A. Pinto, R.A. Campos & A.T. França. (2013) Hereditary angioedema: first report of the Brazilian registry and challenges. Journal of the European Academy of Dermatology and Venereology 27:3, pages e338-e344.
Crossref
Crossref
H. Henry Li, Marilyn Campion, Timothy J. Craig, Daniel F. Soteres, Marc Riedl, William R. Lumry, Andrew J. MacGinnitie, Elizabeth P. Shea & Jonathan A. Bernstein. (2013) Analysis of hereditary angioedema attacks requiring a second dose of ecallantide. Annals of Allergy, Asthma & Immunology 110:3, pages 168-172.
Crossref
Crossref
Sabrina W Cole & Lisa M Lundquist. (2012) Icatibant for the Treatment of Hereditary Angioedema. Annals of Pharmacotherapy 47:1, pages 49-55.
Crossref
Crossref
M. Cicardi, K. Bork, T. Caballero, T. Craig, H. H. Li, H. Longhurst, A. Reshef & B. Zuraw. (2012) Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 67:2, pages 147-157.
Crossref
Crossref
Ugochukwu C. Nzeako & Hilary J. Longhurst. (2012) Many faces of angioedema. European Journal of Gastroenterology & Hepatology, pages 1.
Crossref
Crossref
Sabina Antonela Antoniu. (2011) Therapeutic Approaches in Hereditary Angioedema. Clinical Reviews in Allergy & Immunology 41:1, pages 114-122.
Crossref
Crossref